Fundraising Fox
🦊/People
Sign in

Eric Heil

Investor

Managing Partner at Medical Excellence Capital · Executive at ThirdLaw Molecular

Pennsylvania

Writes $100K – $5M checks · typically $1.5M

Find your path to Eric

565 people in our graph share verified history with Eric — schools, employers, funds. One of them is your warm intro.

Kerry KilleenunlockedEric: together at University of Pennsylvania (2004–2005)
×3Eric: together at The Wharton School
Eric: together at University of Pennsylvania
Eric: together at Easton Associates

About

Eric Heil is a five-time founder and CEO who simultaneously runs companies—currently CEO of Ladder Bio—while co-founding biotech startups and spinning out platforms like ProJenX and RightCare through his fund.

Contact· published on Eric's own website

Invests in

AI & Machine LearningBiotechHealthtechMedical Devices

Executive at ThirdLaw Molecular

Intro paths

→

In turn, Eric can intro founders to ThirdLaw Molecular's investors below.

ThirdLaw Molecular's investors · 1

Medical Excellence CapitalNew York · since 2025

Co-founders at ThirdLaw Molecular

CSChristian Schafmeister
Christian SchafmeisterExecutive Officer, Director

Experience

  1. Medical Excellence Capital, LLCManaging Partnercurrent2021 — presentDoylestown, Pennsylvania, United States
  2. Ladder Bio Inc.Chief Executive Officercurrent2025 — present
  3. GC TherapeuticsBoard Observercurrent2023 — present
  4. ProJenX, Inc.Chair & Board Member (Served as interim founding CEO)current2021 — present
  5. Nobias TherapeuticsBoard Membercurrent2021 — present
  6. Health Quality Partners (HQP)SVP, Global Growth & Opportunity2019 — 2021Doylestown, PA
  7. The Wharton SchoolAdjunct Professor/Co-Instructor - Healthcare Entrepreneurship2016 — 2020Philadelphia, PA
  8. Upward HealthCofounder & Interim Founding CEO2017 — 2018Doylestown, Pennsylvania, United States
  9. naviHealthSVP, Chief Commercial Officer Software Solutions2015 — 2017Horsham, PA
  10. RightCare SolutionsCo-founder, President & CEO2011 — 2015Greater Philadelphia Area
  11. Domain AssociatesEntrepreneur In Residence / Portfolio Company CEO2012 — 2014
  12. Domain AssociatesVenture Capital Associate2011 — 2012Princeton, NJ
  13. Domain AssociatesVenture Capital Analyst2008 — 2010Princeton, NJ
  14. Celator PharmaceuticalsSenior Director, Business Development2010 — 2012Princeton, NJ
  15. Corthera, Inc.Director, Business Development2008 — 2009San Mateo, CA
  16. Bear Stearns & Co.Equity Research Associate - Managed Care2007 — 2008New York, New York
  17. Easton AssociatesResearch Associate2005 — 2006New York, NY
  18. Independence Blue CrossIntern2004Philadelphia, PA

Skills & more

Board of Directors11CEOs9StartupsBusiness Planning3Venture CapitalPortfolio Management18Equity Research5Corporate Development32Mergers4Pharmaceuticals3Healthcare39Valuation13
+8 moreBiotechnologyPharmaceutical IndustryEntrepreneurshipBusiness DevelopmentStrategyMergers & AcquisitionsBusiness StrategyStart-ups
  • Series 63 — Bear Stearns Companies
  • Series 7 — Bear Stearns Companies
  • Venture Capital — Wharton Executive Education

From Eric's professional profile.

Deals · 1

Rejuvitas, Inc.Board seat

via Medical Excellence Capital · filed Sep 2022 · $5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

ProJenX

Per SEC Form D filings.

Colleagues at Medical Excellence Capital

Annabel Stoddart
Office Manager and Executive Assistant at Medical Excellence Capital
Brad Ringeisen
Scientific Advisory Board – Executive Director of Innovative Genomics Institute at Medical Excellence Capital
Brian Halak
Managing Partner at Medical Excellence Capital
Douglas Wallace
Scientific Advisory Board – Director of Center for Mitochondrial and Epigenomic Medicine at Medical Excellence Capital
Gregg Semenza
Scientific Advisory Board – Professor at Johns Hopkins at Medical Excellence Capital
Halak Brian
Promoter at Medical Excellence Capital
Heil Eric
Promoter at Medical Excellence Capital
Joan M Mancini
Promoter at Medical Excellence Capital

Network1

Brian Halak
Managing Partner at Medical Excellence Capital

Investors connected to Eric in public investor directories — a warm-intro map.

Frequently asked questions

Who is Eric Heil?
Eric Heil is a five-time founder and CEO who simultaneously runs companies—currently CEO of Ladder Bio—while co-founding biotech startups and spinning out platforms like ProJenX and RightCare through his fund.
Where does Eric Heil work?
Eric Heil is Managing Partner at Medical Excellence Capital and Executive at ThirdLaw Molecular.
What does Eric Heil invest in?
Eric Heil invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
What check size does Eric Heil write?
Eric Heil typically writes checks of $100K – $5M.
What boards does Eric Heil sit on?
Eric Heil holds tracked board seats at ProJenX, Rejuvitas, Inc..
Where did Eric Heil go to school?
Eric Heil studied at The Wharton School (MBA, MBA for Executives); University of Pennsylvania (BSE, Systems Engineering, Healthcare Systems); Lehigh University (BSE Candidate, Computer Engineering).

Founder mafias

Domain Associates mafia2

Also came through, then founded or led a company.

Heil EricVenture Capital AssociateFounded ProJenX

GC Therapeutics mafia2

Also came through, then founded or led a company.

Heil EricBoard ObserverFounded ProJenX

Ladderbio mafia2

Also came through, then founded or led a company.

Christian SchafmeisterFounderFounded ThirdLaw Molecular

Same school

Shared employers